Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020992

Expand all

CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A)
0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: ESTROGENS, CONJUGATED SYNTHETIC A
Proprietary Name: CENESTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020992
Product Number: 001
Approval Date: Jun 21, 2002
Applicant Holder Full Name: ASPEN PHARMA USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A)
0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: ESTROGENS, CONJUGATED SYNTHETIC A
Proprietary Name: CENESTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020992
Product Number: 005
Approval Date: Feb 5, 2004
Applicant Holder Full Name: ASPEN PHARMA USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A)
0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: ESTROGENS, CONJUGATED SYNTHETIC A
Proprietary Name: CENESTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020992
Product Number: 002
Approval Date: Mar 24, 1999
Applicant Holder Full Name: ASPEN PHARMA USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A)
0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: ESTROGENS, CONJUGATED SYNTHETIC A
Proprietary Name: CENESTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020992
Product Number: 003
Approval Date: Mar 24, 1999
Applicant Holder Full Name: ASPEN PHARMA USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A)
1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: ESTROGENS, CONJUGATED SYNTHETIC A
Proprietary Name: CENESTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020992
Product Number: 004
Approval Date: Mar 13, 2000
Applicant Holder Full Name: ASPEN PHARMA USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information